Concepedia

Gerrit J.A. Vos

GJ

Statistics

Publications

5

Citations

720

H-Index

5

Active since

2018

Affiliations

St. Antonius Ziekenhuis(Current)

University College London

University Medical Center Utrecht

Onze Lieve Vrouwziekenhuis Hospital

Utrecht University

Gerrit J.A. Vos is an author at St. Antonius Ziekenhuis specializing in cardiology, pharmacogenomics in cardiology, and pharmacogenomics.

Publications per year

2018–2021

5

Publications

5

A Genotype-Guided Strategy for Oral P2Y <sub>12</sub> Inhibitors in Primary PCI

Daniel M.F. Claassens, Gerrit J.A. Vos, Thomas O. Bergmeijer et al. · New England Journal of Medicine · 2019 · 624 citations · Full text

, , +16

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial

Daniel M.F. Claassens, Pim W. M. van Dorst, Gerrit J.A. Vos et al. · American Journal of Cardiovascular Drugs · 2021 · 29 citations · Full text

, , +15

Feasibility and Implementation of <i>CYP2C19</i> Genotyping in Patients Using Antiplatelet Therapy

Thomas O. Bergmeijer, Gerrit J.A. Vos, Daniel M.F. Claassens et al. · Pharmacogenomics · 2018 · 27 citations · Full text

, , +17

Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype

Daniel M.F. Claassens, Thomas O. Bergmeijer, Gerrit J.A. Vos et al. · Circulation Cardiovascular Interventions · 2021 · 27 citations · Full text

, , +14

Reasons for early discontinuing or switching of antiplatelet therapy in elderly patients after acute coronary syndrome

Marieke E. Gimbel, Gerrit J.A. Vos, Thuc A. Nguyen et al. · Coronary Artery Disease · 2019 · 13 citations

, , +14

1–5 of 5